SINGAPORE -- French drugmaker Sanofi plans to bring its new vaccine plant in Singapore fully online by the end of 2025 as it looks to tap growing demand for preventive care in an aging Asia.
A groundbreaking ceremony was held Wednesday for the 400 million euro ($434 million) production facility. It was initially slated to start fully operating in the first quarter of 2026, but the company moved up the timeline to match changes to production and sales plans.
